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corticosteroid-Binding Globulin is 
expressed in the adrenal gland and 
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synthesis and secretion in a sex-
dependent manner
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Montserrat esteve1,2,3 & Mar Grasa1,2,3
corticosteroid-binding globulin (cBG) is synthesized by the liver and secreted into the bloodstream 
where binds to glucocorticoids. thus cBG has the role of glucocorticoid transport and free hormone 
control. In addition, CBG has been detected in some extrahepatic tissues without a known role. CBG-
deficient mice show decreased total corticosterone levels with missing of classical sexual dimorphism, 
increased free corticosterone, higher adrenal gland size and altered HPA axis response to stress. Our 
aim was to ascertain whether CBG deficiency could affect the endocrine synthetic activity of adrenal 
gland and if the adrenal gland produces cBG. We determined the expression in adrenal gland of proteins 
involved in the cholesterol uptake and its transport to mitochondria and the main enzymes involved 
in the corticosterone, aldosterone and catecholamine synthesis. The results showed that CBG is 
synthesized in the adrenal gland. CBG-deficiency reduced the expression of ACTH receptor, SRB1 and 
the main genes involved in the adrenal hormones synthesis, stronger in females resulting in the loss 
of sexual dimorphism in corticosteroid adrenal synthesis, despite corticosterone content in adrenal 
glands from CBG-deficient females was similar to wildtype ones. In conclusion, these results point to 
an unexplored and relevant role of cBG in the adrenal gland functionality related to corticosterone 
production and release.
Glucocorticoids are steroid hormones secreted by the adrenal gland that perform pleiotropic functions. Their 
synthesis is regulated through hypothalamic-pituitary-adrenal axis (HPA)1 activity. Disturbance of the HPA axis 
leads to important physiological consequences that significantly affect energy metabolism and immune func-
tion among others2. Corticosteroid-binding globulin (CBG) is the main protein that carries glucocorticoids in 
blood and has high binding affinity for glucocorticoids. Thus, 80% to 90% of glucocorticoids in the bloodstream 
bind to CBG, a small proportion (5% to 10%) binds non-specifically to albumin and about 5% circulates freely3. 
According to the free hormone hypothesis4, the free fraction is available to interact with target cells and therefore 
act as the physiologically active hormone. In this context, CBG has the roles of transport glucocorticoids and con-
trol the amount of free hormone5. CBG is primarily synthesized by the liver and secreted into the bloodstream, 
where it binds to glucocorticoids. Oestrogens are potent inducers of the hepatic synthesis of CBG6, whereas 
interleukin-6 (IL6), insulin and glucocorticoids inhibit its expression7,8. In addition, CBG has been detected 
inside the cells of extrahepatic tissues such as white adipose tissue, lungs, heart, placenta and CNS9–12, although 
its role remains unknown. The enzyme elastase, which is secreted by activated neutrophils, has the capacity to 
cleave CBG, which consequently loses its affinity for glucocorticoids. This has been interpreted as a way to deliver 
glucocorticoids to the inflammation site13. A more active role for the modulation of glucocorticoid action by CBG 
is currently being explored14.
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CBG-deficient mice show lower total corticosterone levels and higher free corticosterone and ACTH15, and 
greater adrenal gland size16, i.e., they have an altered response to the HPA axis. In addition, the sexual dimor-
phism that elicits increased levels of total corticosterone in females with respect to males is eliminated by CBG 
deficiency17,18.
The present study aimed to ascertain whether CBG deficiency affects the synthetic endocrine activity 
of adrenal gland in male and female mice. For this purpose, we investigated in adrenal glands from WT and 
CBG-deficient (KO) mice the expression of: the ACTH receptor (MC2R), the proteins involved in cholesterol 
uptake (scavenger receptor class B member 1, SRB1), and its transport to mitochondria where steroidogenesis 
takes place (steroidogenic acute regulatory protein, StAR) and the main enzymes involved in corticosterone, 
aldosterone and catecholamine synthesis. In addition, we also investigated whether the adrenal gland produces 
CBG. The results showed that CBG is present in the adrenal gland and its absence elicits a female-specific reduced 
expression of the main proteins involved in the adrenal hormone production resulting in the loss of the adrenal 
sexual dimorphism.
Results
Table 1 shows the weight of the animals and their adrenal glands, in addition to total serum and adrenal corticos-
terone levels. As expected in females wild-type (FWT), the adrenal glands were heavier than in males wild-type 
(MWT) and corticosterone serum levels presented a corresponding increase in females. As previously shown, 
the serum corticosterone levels in KO mice were similar in males and females, and lower than those observed 
in WT mice17. By contrast, the weight of the adrenal glands in CBG-deficient (KO) mice was higher than that 
of WT mice and higher in females CBG-deficient (FKO) respect of males CBG-deficient (MKO) despite the 
lack of serum corticosterone differences. Corticosterone content in all the adrenal gland show dimorphism sex-
ual in both WT and KO mice. Respect to WT, KO males showed similar corticosterone values in their adrenal 
glands whereas in females, KO accumulated corticosterone above WT levels without reaching significativity by 
Bonferroni post-test.
The total mRNA obtained from adrenal glands was significantly higher in females than in males (Fig. 1A) 
because of their larger size (Fig. 1B), and there were no differences due to genotype (WT vs KO). The RNA yield 
in µg per mg of adrenal gland tended to be lower in KO mice of both genders, but there were no significant dif-
ferences (Fig. 1B).
CBG mRNA and protein were found in the adrenal glands of WT males and females (Figs 2 and 3). The total 
protein (Fig. 2B) and total CBG protein (Fig. 2C) were higher in females than in males when expressed per gland, 
but these differences disappeared when CBG was calculated per µg of protein (Fig. 2A). However, total mRNA per 
gland tends to decrease in females without being significant (Fig. 2D).
The immunohistochemical analysis (Fig. 3) revealed a positive CBG signal inside the cells of the zona glo-
merulosa and the zona fasciculata, where glucocorticoids are synthesized. Nevertheless there was also a positive 
staining for CBG in the medullary zone, where the adrenal gland produces catecholamines, either in males and 
females.
Figure 4 shows the expression of the ACTH receptor MC2R, the main cellular cholesterol uptake recep-
tor SRB1 and the protein that regulates cholesterol transfer within the mitochondria, StAR. According to the 
increased circulating corticosterone, females exhibited significantly higher expression of all three genes in WT 
mice. The KO mice displayed a reduced expression of MC2R mRNA, which was particularly evident in females. 
In the case of SRB1 and StAR, there were no significant differences between KO and WT males, but the expression 
of these two genes was greatly reduced in KO females.
The expression of the main enzymes involved in steroidogenesis is shown in Fig. 5. There were no differences 
between males and females or among WT and KO mice for Cyp11a1 or Hsd3b1. The expression of Cyp21a1, 
which catalyses the progesterone to deoxycorticosterone conversion, was much higher in females as compared to 
male WT mice. Deficiency of CBG diminished Cyp21a1 expression in both sexes of KO mice, and this effect was 
more pronounced in females.
Parameter Unit MWT MKO FWT FKO
Body weight g 34 ± 1 32 ± 1 24 ± 1χ 23 ± 1χ
Adrenal weight mg 3.56 ± 0.16 4.90 ± 0.37* 5.40 ± 0.35χ 6.43 ± 0.46χ
Adrenal weight % 0.011 ± 0.001 0.015 ± 0.001 0.023 ± 0.001χ 0.029 ± 0.002χ*
Total corticosterone in serum nM 299 ± 48 179 ± 45 878 ± 99χ 266 ± 79*
Corticosterone content in 
adrenal gland pmol 171 ± 51 147 ± 16 260 ± 63 465 ± 109
χ
Table 1. Body, adrenal gland weights and serum and adrenal corticosterone levels in 12-weeks old female and 
male KO and WT mice. The significant results of two-way ANOVA were for body weight due to sex, p < 0.0001; 
adrenal weight in mg due to sex, p < 0.0001 and genotype, p = 0.0034; adrenal weight in % due to sex p < 0.0001 
and genotype p = 0.0009; total corticosterone levels due to sex p > 0.0001, genotype, p > 0.0001 and interaction, 
p = 0.0003 and for corticosterone content in adrenal gland due to sex p = 0.0020 and interaction p = 0.0572. 
Significant Bonferroni post-test: *denotes a significant difference between WT and KO under the appointed 
sex and χdenotes significant difference between males and females of the appointed genotype. Data are 
mean ± SEM of 6 to 10 mice.
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Cyp11b1 expression was higher in females than in males KO, whereas Cyp17a1 displayed the opposite pattern, 
higher expression in males than in females KO mice. Of note, these sexual dimorphisms were not observed in WT 
mice. The expression of Cyp11b2 (corticosterone to aldosterone conversion) did not vary between WT and KO 
males and females, but CBG-deficient mice exhibited a reduced expression compared to WT mice in both sexes.
Figure 6 shows the expression of enzymes involved in catecholamine synthesis. TH converts L-tyrosine to 
Dopa that in turn is transformed in dopamine by DCC. Noradrenaline is produced by DBH from Dopamine. 
Although the expressions tended to decrease in KO mice, the only significant difference was a reduction in DOPA 
decarboxylase (DDC) mainly in female KO, that catalyses the conversion of L-DOPA to dopamine.
Figure 1. Total RNA (A) and RNA yield per mg of tissue (B) obtained from adrenal glands of males and 
females WT and KO (MWT, MKO, FWT and FKO respectively). The results of two-way ANOVA are specified 
in the graphs. Genotype (Gen) and sex (Sex) were the two variables assessed. Significant Bonferroni post-test: 
χdenotes significant difference between males and females of the appointed genotype. Data are mean ± SEM of 
6 to 10 mice.
Figure 2. Western blot of CBG (A) in adrenal protein samples from males and females wild-type with serum 
as positive control and adrenal samples from KO mice as negative controls. Picture is cropped in order to 
eliminate samples of rats from experimental groups not included in this publication. The full picture is provided 
in the Supplementary file; (B) total protein per adrenal gland, (C) total CBG protein per whole adrenal gland 
and D) total mRNA of CBG per adrenal gland expressed as percentage of the expression in males WT. A.U.: 
arbitrary units. The results of t-student: χdenotes significant difference between males and females WT. Data are 
mean ± SEM of 6 to 10 mice.
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Discussion
In humans, it is well known that there are CBG polymorphisms that decrease its affinity for cortisol or its plasma 
levels19–22. The most common symptoms in humans carrying CBG mutations are fatigue, chronic pain, hypo-
tension and, in some cases, overweight or obesity19. An inadequate response of HPA to stress is found in both 
humans and mice lacking functional CBG18,19,23. Deficient CBG mice show reduced total circulating corticoster-
one and increased free corticosterone levels15–17 and exhibit a higher corticosterone turnover rate15 that is consist-
ent with a larger adrenal size16. We therefore investigated whether the lack of CBG had direct consequences on the 
adrenal functionality of the cortical and medullary zones. Furthermore, we determined whether adrenal glands 
produce CBG, as previously described in adipose tissue and lung10,16,17.
Here we show for the first time to our knowledge that adrenal glands express CBG, as previously described 
in other tissues9,10,16,17,24,25. Adrenal glands from males and females presented the same amount of CBG when 
expressed per µg of protein, while the levels were higher in females when expressed per gland, given the larger 
adrenal gland size in females compared to males. The adrenal gland is considered one of the most irrigated tis-
sues26, so the CBG found by western blot may have come from blood. Although we cannot totally rule this out, 
the presence of non-negligible CBG mRNA (about 27–28 cycles) and the location of CBG in the cytosolic com-
partment within cells revealed by the immunohistochemistry analysis indicate that the CBG detected was adrenal 
in origin. We ruled out blood contamination in the immunohistochemistry analysis due to the perfusion with 
paraformaldehyde prior to the adrenal dissection. Even though corticosterone synthesis takes place at adrenal 
cortex level, CBG was also found in the adrenal medulla. A possible explanation is that CBG plays a role in the 
Figure 3. Representative CBG immunohistochemistry of perfunded adrenal glands from wild-type male and 
female mice. CBG + slides were incubated with anti-mouse CBG primary antibody. C- slides were negative 
controls without primary antibody incubation.
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glucocorticoid regulation exerted on catecholamine synthesis27. The HPA axis is known to be involved in the 
regulation of catecholamine synthesis in the sympathetic ganglia and adrenal medulla of rats and mice28,29, but 
in a different way. An increase in ACTH promotes the expression of TH and DBH in sympathetic ganglia, but 
has no effect on their expression in the adrenal medulla30, since the MC2R receptor is only present in the adrenal 
cortex31. However, cortisol favours the synthesis of adrenaline from noradrenaline32,33 in the adrenal medulla27, 
so the presence of CBG could be interpreted as an intracellular carrier able to dose the glucocorticoids that drive 
adrenaline synthesis. This unexpected finding requires further research to ascertain the impact of CBG on adrenal 
gland functionality.
The expression of MC2R, the ACTH receptor, decreased in both male and female KO mice, but this effect was 
only significant in females. Previously, no altered response to ACTH had been reported from cultured adrenal 
cells of males CBG KO mice34, but there were no data from females that, according to our finding, resulted more 
affected. This contrasts with the high levels of ACTH previously described in KO mice15 and the upregulation 
exerted by ACTH on MC2R expression35 and points to a lower response capacity of the adrenal gland in CBG 
KO mice. The marked decrease in the uptake of cholesterol (SRB1) and its transport to the mitochondria (StAR) 
found in females are probably a consequence of the decreased response of the adrenal glands to ACTH that regu-
lates both expressions35,36. The lack of differences between WT and KO males in StAR expression is in agreement 
with previous data34. The study on the expression of the enzymes involved in adrenal steroidogenesis revealed a 
decrease in KO mice of Cyp21a1, which directs progesterone to glucocorticoid synthesis37. Again, this effect was 
more pronounced in KO females in agreement with the reduced synthesis of glucocorticoids in the absence of 
CBG. On the other hand, Cyp11b1 expression in KO females showed a significant increase that could be a com-
pensatory mechanism to the fall of substrate availability due to upstream enzyme down-regulation. Finally, the 
decrease in Cyp11b2 in male and female KO mice again points to a decrease in synthetic activity in the adrenal 
glands of KO mice (Fig. 7).
Ours results reinforce the observation that there is an adrenal weight increase in CBG-deficient mice10 and 
that a lack of CBG is associated with a loss of gender dimorphism in circulating corticosterone17,18. However, this 
lack of sexual dimorphism in circulating corticosterone has no translation in the corticosterone content found in 
adrenal glands. It is worth noting that, in female KO mice, the reduced expression of enzymes for corticosterone 
synthesis is accompanied by an enhanced corticosterone content. Higher adrenal size usually correlates with 
gland hyperactivity38, except in congenital adrenal hyperplasia (CAH)39. Patients with CAH present a natural 
mutation in one of the enzymes involved in cortisol synthesis, more frequently in Cyp21A2 referred also as 
Figure 4. Expression of the ACTH receptor (MCR2), scavenger-receptor B1 (SRB1) involved in cholesterol 
uptake and StAR, the cholesterol carrier into the mitochondria. The results of two-way ANOVA are specified 
in the graphs. Genotype (Gen) and sex (Sex) were the two variables assessed. A.U.: arbitrary units. Significant 
Bonferroni post-test: *denotes a significant difference between WT and KO under the appointed sex and 
χdenotes significant difference between males and females of the appointed genotype. Data are mean ± SEM of 
6 to 10 mice.
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21-hydroxilase (classical CAH) analogous to Cyp21a1 in rodents, which leads to impaired cortisol and adrenalin 
production, larger adrenal size and less vulnerability to psychological stress40. Impaired cortisol production in 
CAH diminishes the negative feedback to the pituitary gland, that responds with enlarging the secretion ACTH, 
resulting in hyperplasia of the adrenal cortex39. According to this, CBG deficient mice with reduced circulating 
corticosterone levels also show increased of circulating ACTH levels15 resulting in adrenal hyperplasia16. Our data 
show that specifically female KO adrenals failed to secrete it, pointed by the increased corticosterone accumula-
tion in the gland. Recently, it have been described that CBG plays a relevant role regulating the steroid hormones 
synthesis in testicular Leydig cells24. Overexpression of CBG promoted StAR and Cyp17a1 expression and proges-
terone release and CBG knockdown triggered the opposite response, decreasing enzyme expression and hormone 
release. These data has lead the authors to propose a new CBG role as hormone transporter from inside cell tissue. 
According to this role, in our model, the absence of CBG hinder the normal adrenal corticosterone production 
and release. The role of CBG is multiple and complex and its levels determine the HPA axis dimorphism in rats41. 
Here, we propose that CBG could facilitate corticosterone export from adrenal gland in stressful situations with 
high corticosterone output as fasting42. According to the double CBG action, females would be the more affected 
by CBG deficiency. Here we also found a decreased Cyp11b2 expression consistently with a mineralocorticoid 
Figure 5. Expression of the main enzymes involved in steroid synthesis in the adrenal gland: Cyp11a1, Hsd3b1, 
Cyp21a1, Cyp11b1, Cyp11b2 and Cyp17a1. The results of two-way ANOVA are specified in the graphs. 
Genotype (Gen) and sex (Sex) were the two variables assessed. Interaction (Int) is included when p < 0.1. A.U.: 
arbitrary units. Significant Bonferroni post-test: *denotes a significant difference between WT and KO under 
the appointed sex and χdenotes significant difference between males and females of the appointed genotype. 
Data are mean ± SEM of 6 to 10 mice.
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Figure 6. Expression of the main enzymes involved in catecholamine synthesis in adrenal gland: tyrosine 
hydroxylase (TH), dopamine β-hydroxylase (DBH) and DOPA decarboxylase (DDC). The results of two-
way ANOVA are specified in the graphs. Genotype (Gen) and sex (Sex) were the two variables assessed. A.U.: 
arbitrary units. Significant Bonferroni post-test: *denotes a significant difference between WT and KO under 
the appointed sex and χdenotes significant difference between males and females of the appointed genotype. 
Data are mean ± SEM of 6 to 10 mice.
Figure 7. Schema of adrenal steroidogenesis where the enzymes that have been studied are shown. It is 
indicated with green down-arrows when the lack of CBG causes a decrease in their expression in females.
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synthesis decreases. Accordingly, individuals with CAH have mineralocorticoid synthesis decreased because the 
lack of substrate available for Cyp11b2 and resulting in a salt wasting39. Finally, the subjects with classical CAH 
with a block in cortisol biosynthesis shifts precursors to pathways that make excess adrenal-derived androgens39. 
Related to this, here we observed a tendency to increase, but not significant, the expression of Cyp17a1 in male 
KO and decreased expression in female KO mice. Given that this is poorly expressed in the adrenal glands of 
rodents43 (with a Ct of about 30 for Cyp17a1, while the rest of the enzymes presented a Ct of 15–20), the conse-
quences in the overall androgen production are probably not relevant in CBG KO mice.
In conclusion, our results show that CBG is present in the adrenal gland and provide evidence that the lack of 
CBG leads to a reduction in the adrenal synthesis of glucocorticoids, and the capacity to secrete corticosterone in 
response to stressful stimuli23,34. The effect on adrenal glucocorticoid synthesis and secretion due to lack of CBG 
was strongest in females that could be related with different emotional reactivity in females previously reported18. 
The data here shown point to a relevant, yet unexplored, role for CBG enabling corticosterone synthesis and deliv-
ery to the blood and open the path to further studies unraveling this intriguing finding.
Methods
Animals and experimental protocol. Twelve-week old wild-type (WT) and CBG-deficient (KO) mice 
were used. The KO colony was established by crossing heterozygous breeding pairs, which were kindly provided 
by Dr. Willnow. The procedure to disrupt the CBG gene was described by Petersen et al.15. The mice were divided 
into four groups of six to 10 animals: WT males (MWT), KO males (MKO), WT females (FWT) and KO females 
(FKO). The animals were housed in a controlled environment, fed a standard laboratory pelleted formula (Teklad 
Global 2018, Harlan-Interfauna Ibérica, Sant Feliu de Codines, Spain) and had access to tap water ad libitum. 
Before killing, the mice were fasted overnight in order to induce corticosterone secretion. The mice were killed 
under isoflurane anaesthesia between 7 a.m. and 9 a.m., and the adrenal glands were carefully dissected, weighed 
and frozen at −80 °C until use. Blood samples were obtained and centrifuged to obtain serum. For the histological 
analysis, a number of animals, following their death, were perfused with paraformaldehyde to fix the tissue. All 
procedures were conducted in accordance with the guidelines for the use of experimental animals established by 
the European Union, Spain and Catalonia, and were approved by the University of Barcelona Animal Handling 
Ethics Committee.
total corticosterone. Corticosterone in serum and adrenals was measured by radioimmunoassay using a 
sheep anti-corticosterone antibody (AB1297, Millipore, USA) as described previously44.
Western blot and corticosterone content from adrenal gland homogenates. Homogenates from 
one adrenal gland were prepared in 300 µL of PBS buffer containing 1/100 Complete™ protease inhibitor cocktail 
(Sigma). Samples were homogenized on ice using an Ultra-Turrax T10 (IKA). After a 1000 g centrifugation for 
10 min at 4 °C, the pellet was discarded and the supernatant was collected and stored at −80 °C until use. Protein 
concentration of homogenates was measured with the Bradford reagent (Dye Reagent Concentrate, Bio-Rad 
Laboratories).
Adrenal homogenate samples (25 µg of protein) were separated by SDS/PAGE in a 10% acrylamide gel and 
electrotransferred to a PVDF membrane (Millipore). After blocking nonspecific binding sites with 5% nonfat 
milk and in TBSTween 0.05% for 90 minutes at room temperature, the membranes were incubated overnight with 
a CBG goat anti-mouse polyclonal antibody (LS-C39044, LifeSpan) and β-actin as control (A-5316, Sigma). The 
immunoreactive proteins were further detected by an anti-goat horseradish peroxidase-conjugated secondary 
antibody (sc-2922, Santa Cruz Biotechnology) and using Pierce ECL (Thermo Fisher Scientific). The quantifica-
tion was carried out using Total Lab v2003.3 (Non-Linear Dynamics). Homogenate samples were deproteinized 
with cold acetone. After centrifugation, supernatants were dried under nitrogen gas and resuspendend 1/100 in 
PBS. Corticosterone content in these extracts was measured by radioimmunoassay as previously indicated.
RNA isolation and RT-PCR. The total RNA from one adrenal gland was extracted using the TRI 
Reagent Solution (Ambion, Inc.). The RNA was quantified by measuring the absorbance at 260 nm and 
280 nm using a NanoDrop ND-1000 spectrophotometer (NanoDrop Technologies). The cDNA was synthe-
sized using MMLV reverse transcriptase (Promega) and oligo-dT primers (Attendbio), and reverse tran-
scription was then performed using 2 μg of the RNA sample. Real-time PCR was conducted with SYBRGreen 
Master Mix (Life Technologies) on an ABI PRISM 7900 HT system (Applied Biosystems) using 10 μL of 
amplification mixtures containing 10 ng of reverse-transcribed RNA and 300 nM of the correspondent for-
ward and reverse primers. Primer sequences used were: corticosteroid-binding globulin (CBG) forward: 
5′-GGAAAATTGAGCATGTGGTCT-3′ reverse: 5′-AACTAATGTTGCCTGACTGG-3′; ACTH receptor 
(MCR2) forward: 5′-AGAACCAACATGAAGGGTGC-3′ reverse: 5′-AAGGGGGCCCAACAGAAGAT-3′; 
s cavenger-receptor  B1  (SRB1)  for ward:  5 ′ -AAAGGGCTCCCAGGATAAGGA-3 ′  re vers e : 
5′-GAGTCCTCAAGAAGCGGGGT-3′ ; steroidogenic acute regulatory protein (StAR) forward: 
5′-TGCCAACACCCACTCATACT-3′ reverse: 5′-CCTTCTTTGGGGTGTCTGCAT-3′; cytochrome P450 family 
21a1 (Cyp11a1) forward: 5′-GGTTCCACTCCTCAAAGCCA-3′ reverse 5′-GGATCTCGACCCATGGCAAA-3′; 
3beta-hydroxysteroid dehydrogenase isomerase 1 (Hsd3b1) forward: 5′-AAGCTGCAGACAAAGACCAAGG-3′ 
reverse: 5′-GCTTGAACACAGGCCTCCAA-3′ ;  Cytochrome P450 family 21a1 (Cyp21a1) for-
ward: 5 ′-CTTTCCTGCTTCACCACCCTG-3 ′  reverse: 5 ′-CCTTGGATGTTGGGGATGATG-3 ′ ; 
cytochrome P450 family 11b1 (Cyp11b1) forward: 5′-GCCTGAACGCTATATGCCTC-3′ reverse: 
5 ′-CACGTGGAAGGAT T TCAGCAC-3 ′ ;  cytochrome P450 family 11b2 (Cyp11b2) for wad: 
5′-AGCATCGCTGCAAATCCTCA-3′ reverse: 5′-GGTTTCGGCCCATGGAGTAG-3′; cytochrome 
P 4 5 0  f a m i l y  1 7 a 1  ( C y p 1 7 a 1 )  f or w a rd :  5 ′ - C T G G G C AC T G C AT C AC G ATA- 3 ′  r e v e r s e : 
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5′-GATAAAGAGCTCCTGCCGGG-3′; tyrosine hydroxylase (Th) forward: 5′-CAGCCGGTGTACTTCGTGT-3′ 
r e v e r s e  5 ′ - T C AT C C T G G AC C C C C T C TA AG - 3 ′ ;  d o p a - d e c a r b o x y l a s e  ( D D C )  f o r w a r d : 
5′-TGCTACGCTTTGCTGTGTG-3′ reverse: 5-ACGAAGACGGAGTGGTAGTTA-3′; dopamine β-hydroxylase 
(DBH) forward: 5′-TGACTACGCCCCTATCTCCA-3′ reverse: 5′-GCGTGGAGGTGATCTTAGGC-3′ and for 
cyclophilin forward: 5′-GAGACTTCACCAGGGGAGATG-3′ reverse: 5′-GAGCCATTGGTGTCTTTGCC-3′. 
The specificity of the amplicons was determined by melting curve analysis. The ratio of the relative expression of 
target genes to cyclophilin was calculated by the ΔC(t) formula.
immunohistochemical analysis. Adrenals were obtained from 5 male and 5 female mice perfused with 
40 g/L paraformaldehyde, embedded in paraffin and cut into 5 μm thick sections. For the immunohistochemical 
analysis, the sections were deparaffinized, rehydrated and washed in PBS-Tween. They were then treated with 
0.3% hydrogen peroxide, blocked with 5% rabbit serum and incubated overnight at 4 °C with goat anti-mouse 
CBG (LS-C39044, LifeSpan BioSciences, USA) diluted 1:100. Then, slides were incubated with biotinylated rab-
bit anti-goat (1:400) and signal detection was performed with an avidin-biotin peroxidase complex (Vectastain 
ABC Kit, Vector Labs) and developed with diaminobenzidine hydrochloride chromogen (Sigma). The slides were 
visualized by light microscopy (Olympus BX-51) and image were captured with Olympus DP-70 Digital Camera 
System.
Statistics. The data were expressed as means ± SEM and analysed using GraphPad 5.0. Statistical compar-
isons were obtained by two-way ANOVA to evaluate the impact of sex and genotype (named “Sex” and “Gen”, 
respectively, in the graphs). Interaction significance is also included (“Int”). A significant interaction would 
denote a different response in the mice of each genotype, depending on sex. The Bonferroni post-test was used as 
a multiple comparison method to evaluate significant differences between data pairs. For the CBG western results, 
the Student’s t-test was used to compare MWT and FWT mice because adrenals from KO mice, as expected, failed 
to show CBG. P values below 0.05 were considered significant.
Data Availability
All the data presented here will be available under request to the scientific community.
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